Anti-Diabetic Treatment Regulates Pro-Fibrotic TGF-β Serum Levels in Type 2 Diabetics

Diabetology and Metabolic Syndrome - United Kingdom
doi 10.1186/1758-5996-5-48
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Uric Acid in Type 2 Diabetics

Annals of the College of Medicine, Mosul
2008English

Serum Progranulin Levels in Type 2 Diabetic Patients With Metabolic Syndrome

Romanian Journal of Internal Medicine
Medicine
2016English

Glycosuria Lowers Serum Uric Acid in Type 2 Diabetics

GOUT AND NUCLEIC ACID METABOLISM
2018English

338 Pro-Fibrotic Phenotype of Human Skin Fibroblasts Induced by Periostin via Modulating TGF-β Signaling

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Serum Levels of Chemerin and Omentin 1 in Obese Type 2 Diabetic Patients.

International Journal of Advanced Research
2016English

Rac1 GTPase Regulates 11β Hydroxysteroid Dehydrogenase Type 2 and Fibrotic Remodeling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling Through an Interaction With the TGF-β Type I Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Serum Calcium Levels in Type 2 Diabetes Mellitus

IOSR Journal of Dental and Medical Sciences
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy